REVIEWS AND LECTURES
Due to the fact that acquired myasthenia gravis is an autoimmune disease, so rational treatment of these patients includes the symptomatic therapy (acetylcholinesterase inhibitors, potassium supplements, potassiumsaving diuretics), short-term immunotherapy (intravenous immunoglobulin, methods of extracorporeal hemocorrection), longterm immunotherapy (glucocorticosteroids, cytotoxic agents, targeted therapies), thymectomy, as well as a number of new promising therapeutic agents. The choice of effective therapy depends on identifying the clinical forms of myasthenia gravis and a complete analysis of autoimmune mechanisms underlying the disease because of similar clinical forms of myasthenia gravis may respond to similar therapies.
HEALTH CARE ORGANIZATION
ORIGINAL PAPERS
The results of biomechanical analysis of the motor function of the arm of poststroke patient in the process of neuroreha bilitation with exoskeleton of the hand controlled by brain – computer interface are presented in this paper. At the beginning and end of the course it was registered the kinematic portrait of the patient– isolated random movements for each of the seven degrees of freedom as the paretic and intact arms.
Angular accelerations were taken as an assessment of muscle forces, the number of reverse movements was taken as an assessment of joint spasticity, and the kinematic content of the movement as a description of pathological synergy arising after stroke. These parameters give an objective numerical asses sment of motor function as well as of rehabilitation technology effectiveness.
BRIEF INFORMATION
ISSN 2541-8807 (Online)